BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.20
-0.20 (-0.73%)
Last updated: Oct 1, 2026, 3:34 PM CET
BioVersys AG Revenue
BioVersys AG had revenue of 2.02M CHF in the half year ending June 30, 2026, with 327.12% growth. This brings the company's revenue in the last twelve months to 4.62M, up 253.17% year-over-year. In the year 2025, BioVersys AG had annual revenue of 3.18M with 161.75% growth.
Revenue (ttm)
4.62M
Revenue Growth
+253.17%
P/S Ratio
34.51
Revenue / Employee
121.66K
Employees
38
Market Cap
159.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.18M | 1.96M | 161.75% |
| Dec 31, 2024 | 1.21M | 74.00K | 6.50% |
| Dec 31, 2023 | 1.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.